Check out our report section, press releases and stock details to learn more about the Health Biosciences world.
A solid holding company, made up of valuable professionals
BOARD OF DIRECTORS
BOARD OF STATUTORY AUDITORS
|Alessandro Zindato||Alternate Auditor|
|Mario Moretti||Alternate Auditor|
INFORMATION FOR SHAREHOLDERS
The share capital of Health Biosciences S.p.A. it is equal to € 5.475.985,00 represented by 10.951.970 ordinary shares. Data updated to 24 July 2020
|SHAREHOLDING||NUMBER OF STOCKS||% ON SHARE CAPITAL|
|Health Italia||9.382.172||87,15 %|
|Stock market||1.569.798||12,85 %|
Data being updated
Anyone holding at least 5% of the share capital of Health Biosciences S.p.A. is a "Significant Shareholder".
Each shareholder has the obligation, pursuant to art. 8 of the Articles of Association, to inform the Company of the achievement or exceeding of a participation equal to 5%, 10%, 15%, 20%, 25%, 30%, 50%, 66.6%, 90% of the share capital with the right to vote, as well as to communicate any subsequent reductions, within 3 days from the date of the occurrence of such event (so-called "Substantial Change").
To this end, within 3 trading days, starting from the day on which the transaction involving the Substantial Change was carried out, the Significant Shareholder must notify Health Biosciences S.p.A .:
- the identity of the significant shareholders involved;
- the date when Health Biosciences S.p.A. has been informed;
- the date on which the Substantial Change occurred in the investments;
- the price, amount and category of financial instruments involved;
- the nature of the operation;
- the nature and extent of the Significant Shareholder's participation in the transaction.
The communication must be made using the attached form, sent by e-mail to firstname.lastname@example.org and then sent in original by registered mail with return receipt to the administrative body at the company's registered office or via communication to the dedicated certified email address email@example.com.